131 related articles for article (PubMed ID: 19683931)
1. A critical electrostatic interaction mediates inhibitor recognition by human asparagine synthetase.
Ikeuchi H; Meyer ME; Ding Y; Hiratake J; Richards NG
Bioorg Med Chem; 2009 Sep; 17(18):6641-50. PubMed ID: 19683931
[TBL] [Abstract][Full Text] [Related]
2. A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.
Ikeuchi H; Ahn YM; Otokawa T; Watanabe B; Hegazy L; Hiratake J; Richards NG
Bioorg Med Chem; 2012 Oct; 20(19):5915-27. PubMed ID: 22951255
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Sulfoximine Carbamates by Rhodium-Catalyzed Nitrene Transfer of Carbamates to Sulfoxides.
Zenzola M; Doran R; Luisi R; Bull JA
J Org Chem; 2015 Jun; 80(12):6391-9. PubMed ID: 25989821
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of an N-acylsulfonamide inhibitor of human asparagine synthetase.
Koroniak L; Ciustea M; Gutierrez JA; Richards NG
Org Lett; 2003 Jun; 5(12):2033-6. PubMed ID: 12790521
[TBL] [Abstract][Full Text] [Related]
5. Mapping the aspartic acid binding site of Escherichia coli asparagine synthetase B using substrate analogs.
Parr IB; Boehlein SK; Dribben AB; Schuster SM; Richards NG
J Med Chem; 1996 Jun; 39(12):2367-78. PubMed ID: 8691431
[TBL] [Abstract][Full Text] [Related]
6. Asparagine synthetase chemotherapy.
Richards NG; Kilberg MS
Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
[TBL] [Abstract][Full Text] [Related]
7. Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase.
Ciustea M; Gutierrez JA; Abbatiello SE; Eyler JR; Richards NG
Arch Biochem Biophys; 2005 Aug; 440(1):18-27. PubMed ID: 16023613
[TBL] [Abstract][Full Text] [Related]
8. An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.
Gutierrez JA; Pan YX; Koroniak L; Hiratake J; Kilberg MS; Richards NG
Chem Biol; 2006 Dec; 13(12):1339-47. PubMed ID: 17185229
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
[TBL] [Abstract][Full Text] [Related]
10. Kinetic mechanism of asparagine synthetase from Vibrio cholerae.
Fresquet V; Thoden JB; Holden HM; Raushel FM
Bioorg Chem; 2004 Apr; 32(2):63-75. PubMed ID: 14990305
[TBL] [Abstract][Full Text] [Related]
11. A convenient gHMQC-based NMR assay for investigating ammonia channeling in glutamine-dependent amidotransferases: studies of Escherichia coli asparagine synthetase B.
Li KK; Beeson WT; Ghiviriga I; Richards NG
Biochemistry; 2007 Apr; 46(16):4840-9. PubMed ID: 17397190
[TBL] [Abstract][Full Text] [Related]
12. Asparagine synthetase: Function, structure, and role in disease.
Lomelino CL; Andring JT; McKenna R; Kilberg MS
J Biol Chem; 2017 Dec; 292(49):19952-19958. PubMed ID: 29084849
[TBL] [Abstract][Full Text] [Related]
13. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
[TBL] [Abstract][Full Text] [Related]
14. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
[TBL] [Abstract][Full Text] [Related]
15. Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.
He Y; Li B; Luo C; Shen S; Chen J; Xue H; Tang J; Gu L
J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):159-163. PubMed ID: 21505976
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.
Abbatiello SE; Pan YX; Zhou M; Wayne AS; Veenstra TD; Hunger SP; Kilberg MS; Eyler JR; Richards NG; Conrads TP
J Proteomics; 2008 Apr; 71(1):61-70. PubMed ID: 18541474
[TBL] [Abstract][Full Text] [Related]
17. Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
Pan Y; Suzuki T; Sakai K; Hirano Y; Ikeda H; Hattori A; Dohmae N; Nishio K; Kakeya H
Eur J Pharmacol; 2023 Dec; 960():176156. PubMed ID: 38059445
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the asparagine synthetase level in leukemia cells by monoclonal antibodies.
Kusano-Arai O; Iwanari H; Mochizuki Y; Nakata H; Kodama T; Kitoh T; Hamakubo T
Hybridoma (Larchmt); 2012 Oct; 31(5):325-32. PubMed ID: 23098298
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of L-asparaginase and the effects of host and enzyme modification.
Uren JR
Cancer Treat Rep; 1981; 65 Suppl 4():47-55. PubMed ID: 6125260
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.
Nakamura A; Nambu T; Ebara S; Hasegawa Y; Toyoshima K; Tsuchiya Y; Tomita D; Fujimoto J; Kurasawa O; Takahara C; Ando A; Nishigaki R; Satomi Y; Hata A; Hara T
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7776-E7785. PubMed ID: 30061420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
